Last reviewed · How we verify
Nutriflex Omega special + Oxepa
Nutriflex Omega special + Oxepa is a parenteral nutrition formulation that provides essential fatty acids, amino acids, and micronutrients to support metabolic function and reduce inflammatory markers in critically ill patients.
Nutriflex Omega special + Oxepa is a parenteral nutrition formulation that provides essential fatty acids, amino acids, and micronutrients to support metabolic function and reduce inflammatory markers in critically ill patients. Used for Nutritional support in critically ill patients, Acute respiratory distress syndrome (ARDS), Sepsis and systemic inflammatory response.
At a glance
| Generic name | Nutriflex Omega special + Oxepa |
|---|---|
| Sponsor | B. Braun Melsungen AG |
| Drug class | Parenteral nutrition formulation |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Intensive Care Medicine |
| Phase | Phase 3 |
Mechanism of action
Nutriflex Omega special is a lipid emulsion-based parenteral nutrition containing omega-3 and omega-6 polyunsaturated fatty acids designed to support immune function and reduce inflammation. Oxepa is an enteral/parenteral nutrition product enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants to modulate the inflammatory response in acute respiratory distress syndrome and critical illness.
Approved indications
- Nutritional support in critically ill patients
- Acute respiratory distress syndrome (ARDS)
- Sepsis and systemic inflammatory response
Common side effects
- Hypertriglyceridemia
- Hyperglycemia
- Hepatic dysfunction
- Infusion site reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nutriflex Omega special + Oxepa CI brief — competitive landscape report
- Nutriflex Omega special + Oxepa updates RSS · CI watch RSS
- B. Braun Melsungen AG portfolio CI